PML Nuclear Body Component Sp140 Is a Novel Autoantigen in Primary Biliary Cirrhosis-Reference-Cited by-同舟云学术

PML Nuclear Body Component Sp140 Is a Novel Autoantigen in Primary Biliary Cirrhosis

Published:2010-01 Issue:1 Volume:105 Page:125-131
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Granito Alessandro,Yang Wei-Hong,Muratori Luigi,Lim Mark J,Nakajima Ayako,Ferri Silvia,Pappas Georgios,Quarneti Chiara,Bianchi Francesco B,Bloch Donald B,Muratori Paolo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/ajg2009596.pdf

Reference43 articles.

1. Primary biliary cirrhosis.;Kumagi;Orphanet J Rare Dis,2008

2. Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?;Yang;Clin Gastroenterol Hepatol,2004

3. DE, Pares A, Zachou K et al. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis.;Rigopoulou;Gut,2005

4. CJ. Antinuclear antibodies specific for primary biliary cirrhosis.;Worman;Autoimmun Rev,2003

5. Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders.;Muratori;Clin Exp Immunol,2002

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pruritus, Fatigue, Osteoporosis and Dyslipoproteinemia in Pbc Patients: A Clinician’s Perspective;Gastroenterology Insights;2024-05-17

2. SP140 inhibitor suppressing TRIM22 expression regulates glioma progress through PI3K/AKT signaling pathway;Brain and Behavior;2024-03

3. The axis of complement C1 and nucleolus in antinuclear autoimmunity;Frontiers in Immunology;2023-06-09

4. SP140 inhibits STAT1 signaling, induces IFN-γ in tumor-associated macrophages, and is a predictive biomarker of immunotherapy response;Journal for ImmunoTherapy of Cancer;2022-12

5. Immunologic Responses and the Pathophysiology of Primary Biliary Cholangitis;Clinics in Liver Disease;2022-11